Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

3 Results

Guidelines and Advice

Adjuvant Hormonal Therapy for Stage I Endometrial Cancer

Status: Archived
ID: 4-14

Oct 2007

Guidelines and Advice

Alemtuzumab for the Treatment of T-cell Prolymphocytic Leukemia

Status: Archived
ID: 6-22

Jan 2007

Guidelines and Advice

An Endorsement of the 2023 International Stereotactic Radiosurgery Society’s (ISRS) Guideline: A Systematic Review Informing the Management of Symptomatic Brain Radiation Necrosis After Stereotactic Radiosurgery and ISRS Recommendations

Status: Current
ID: Guideline Endorsement C50-CIDAP-3

Updated

Mar 2025